Book your spot for our new live webinar about Product Listing & Facility Registration for cosmetics in the US market, on October 10th
.
Webinar – MoCRA: Safety Substantiation
Book your spot for our new live webinar about Safety Substatiation for cosmetics in the US market, on September 26th
.
Live Webinar – Adverse event reporting for cosmetics in the US market: addressing serious incidents and reporting to the FDA
Save the date for September 19th! Join our free live webinar – Adverse event reporting for cosmetics in the US market: Addressing serious incidents and reporting to the FDA.
Responsible Person and US Agent — Key roles for compliance under MoCRA
Discover the difference between the Responsible Person and US Agent and the key roles for compliance under MoCRA!
The FDA published its first Guidance on MoCRA – Cosmetic product listing and facility registration
The US Food and Drug Administration (FDA) published the first draft Guidance on the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).
Adulterated and misbranded cosmetics – What to avoid to ensure compliance with the law
The Food, Drug, and Cosmetic (FD&C) Act is the primary federal law regulating cosmetic products…
Selling Cosmetics in the EU & US: What Are the Differences?
In this webinar we will be focusing on the regulatory differences between selling cosmetics in…
How to label a cosmetic product for the US market
Labelling is part of the identity of a cosmetic product, so it is an essential…
MoCRA Products Registration vs “Old” Voluntary Cosmetic Registration Program
One of the many changes introduced by MoCRA is the mandatory registration of cosmetic products…
Welcome to Obelis.us!
Obelis.us is the website of Obelis USA LLC, a branch of Obelis Group established in…